268 related articles for article (PubMed ID: 15941776)
1. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
2. [Activity of macrolides and fluoroquinolones against intracellular Legionella pneumophila].
Yu LL; Hu BJ; Huang SL; Zhou ZY; Tao LL
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Jun; 34(6):409-12. PubMed ID: 21781510
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
4. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.
Tano E; Cars O; Löwdin E
J Antimicrob Chemother; 2005 Jul; 56(1):240-2. PubMed ID: 15919770
[TBL] [Abstract][Full Text] [Related]
6. Comparative activity of ciprofloxacin, ofloxacin, levofloxacin, and erythromycin against Legionella species by broth microdilution and intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
Diagn Microbiol Infect Dis; 1998 Jan; 30(1):37-43. PubMed ID: 9488830
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionella pneumophila and its pharmacokinetics in guinea pigs with L. pneumophila pneumonia.
Edelstein PH; Shinzato T; Doyle E; Edelstein MA
Antimicrob Agents Chemother; 2001 Aug; 45(8):2204-9. PubMed ID: 11451675
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
[TBL] [Abstract][Full Text] [Related]
9. Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
Baltch AL; Smith RP; Ritz WJ; Franke MA; Michelsen PB
J Antimicrob Chemother; 2000 Jul; 46(1):51-5. PubMed ID: 10882688
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility study of BMS-284756 against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 2001; 41(1-2):79-82. PubMed ID: 11687318
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Baltch AL; Smith RP; Franke MA; Michelsen PB
Antimicrob Agents Chemother; 1998 Dec; 42(12):3153-6. PubMed ID: 9835507
[TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Gómez-Lus R; Adrián F; del Campo R; Gómez-Lus P; Sánchez S; García C; Rubio MC
Int J Antimicrob Agents; 2001 Jul; 18(1):49-54. PubMed ID: 11463526
[TBL] [Abstract][Full Text] [Related]
13. Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Smith RP; Baltch AL; Franke M; Hioe W; Ritz W; Michelsen P
J Antimicrob Chemother; 1997 Nov; 40(5):673-8. PubMed ID: 9421315
[TBL] [Abstract][Full Text] [Related]
14. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
Stout JE; Sens K; Mietzner S; Obman A; Yu VL
Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
[TBL] [Abstract][Full Text] [Related]
16. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of olamufloxacin (HSR-903) against Legionella spp.
Higa F; Arakaki N; Tateyama M; Koide M; Shinzato T; Kawakami K; Saito A
J Antimicrob Chemother; 2003 Dec; 52(6):920-4. PubMed ID: 14613952
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
Naber KG; Hollauer K; Kirchbauer D; Witte W
Int J Antimicrob Agents; 2000 Nov; 16(3):239-43. PubMed ID: 11091042
[TBL] [Abstract][Full Text] [Related]
19. Cellular accumulation of fluoroquinolones is not predictive of their intracellular activity: studies with gemifloxacin, moxifloxacin and ciprofloxacin in a pharmacokinetic/pharmacodynamic model of uninfected and infected macrophages.
Vallet CM; Marquez B; Ngabirano E; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
Int J Antimicrob Agents; 2011 Sep; 38(3):249-56. PubMed ID: 21764262
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]